ES2028342T3 - Composicion elastomera de silicona que contiene yodo y que reticula por reaccion de policondensacion. - Google Patents

Composicion elastomera de silicona que contiene yodo y que reticula por reaccion de policondensacion.

Info

Publication number
ES2028342T3
ES2028342T3 ES198888420064T ES88420064T ES2028342T3 ES 2028342 T3 ES2028342 T3 ES 2028342T3 ES 198888420064 T ES198888420064 T ES 198888420064T ES 88420064 T ES88420064 T ES 88420064T ES 2028342 T3 ES2028342 T3 ES 2028342T3
Authority
ES
Spain
Prior art keywords
silicone elastomer
reticulating
composition containing
polycondensation reaction
elastomer composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888420064T
Other languages
English (en)
Inventor
Thierry Prazuck
Ghislaine Torres
Guy Cyprien
Alain Fisch
Johnny Haggiage
Hugues Porte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhodia Chimie SAS
Original Assignee
Rhone Poulenc Chimie SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Chimie SA filed Critical Rhone Poulenc Chimie SA
Application granted granted Critical
Publication of ES2028342T3 publication Critical patent/ES2028342T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00—Use of inorganic substances as compounding ingredients
    • C08K3/16—Halogen-containing compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/2036—Silicones; Polysiloxanes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/09—Carboxylic acids; Metal salts thereof; Anhydrides thereof
    • C08K5/098—Metal salts of carboxylic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Silicon Polymers (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Treatment Of Water By Oxidation Or Reduction (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UNA COMPOSICION DIORGANOPOLISILOXANA ENDURECIBLE EN UN ELASTOMERO DE SILICONA POR REACCIONES DE POLICONDENSACION QUE COMPORTAN UN COMPUESTO DE IODO ORGANICO Y/O MINERAL, LIQUIDO O SOLIDO A TEMPERATURA AMBIENTE NO TOXICA, SOLUBLE EN AGUA Y QUE NO INHIBE EL CATALIZADOR DE ENDURECIMIENTO. LAS COMPOSICIONES ENDURECIDAS EN ELASTOMERO SON UTILIZABLES PARA EL TRATAMIENTO Y LA ERRADICACION DE ENFERMEDADES DEBIDAS A UNA CARENCIA DE IODO.
ES198888420064T 1987-02-26 1988-02-23 Composicion elastomera de silicona que contiene yodo y que reticula por reaccion de policondensacion. Expired - Lifetime ES2028342T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8702883A FR2611734B1 (fr) 1987-02-26 1987-02-26 Composition elastomere silicone polycondensation contenant de l'iode pour le traitement des eaux

Publications (1)

Publication Number Publication Date
ES2028342T3 true ES2028342T3 (es) 1992-07-01

Family

ID=9348559

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888420064T Expired - Lifetime ES2028342T3 (es) 1987-02-26 1988-02-23 Composicion elastomera de silicona que contiene yodo y que reticula por reaccion de policondensacion.

Country Status (12)

Country Link
US (1) US5114707A (es)
EP (1) EP0283408B1 (es)
JP (1) JPS63243163A (es)
AT (1) ATE71396T1 (es)
AU (1) AU596500B2 (es)
BR (1) BR8800803A (es)
CA (1) CA1308837C (es)
DE (1) DE3867510D1 (es)
ES (1) ES2028342T3 (es)
FR (1) FR2611734B1 (es)
GR (1) GR3004218T3 (es)
ZA (1) ZA881327B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2611733B1 (fr) * 1987-02-26 1989-06-16 Rhone Poulenc Chimie Composition a base de gomme diorganopolysiloxane contenant de l'iode pour le traitement des eaux
FR2611735B1 (fr) * 1987-02-26 1989-06-16 Rhone Poulenc Chimie Composition elastomere silicone polyaddition contenant de l'iode pour le traitement de l'eau
GB8704755D0 (en) * 1987-02-28 1987-04-01 Dow Corning Ltd Pharmaceutical delivery device
FR2634772A1 (fr) * 1988-07-29 1990-02-02 Rhone Poulenc Chimie Composition a base d'huile diorganopolysiloxane contenant de l'iode pour le traitement des eaux
FR2648143B1 (fr) * 1989-06-08 1991-09-06 Rhone Poulenc Chimie Composition comprenant un copolymere silicone thermoplastique et un compose de l'iode, utilisable apres sa mise en forme, pour le traitement des eaux
US5833665A (en) 1990-06-14 1998-11-10 Integra Lifesciences I, Ltd. Polyurethane-biopolymer composite
FR2707660A1 (fr) * 1993-07-02 1995-01-20 Rhone Poulenc Chimie Système élastomère silicone et utilisation dudit système comme agent de libération de chlore actif.
CN1055393C (zh) * 1996-06-13 2000-08-16 中国人民解放军59174部队 饮水缓释补碘剂
US20070172518A1 (en) 2004-03-12 2007-07-26 Dow Corning Corporation Method of making silicone pressure sensitive adhesives for delivering hydrophilic drugs
WO2009045941A1 (en) * 2007-10-02 2009-04-09 World Minerals, Inc. Enhanced retention capabilities through methods comprising surface treatment of functional particulate carrier materials, and functional particulate carrier materials made therefrom
HUP1000362A2 (en) 2010-07-12 2012-11-28 Egis Gyogyszergyar Nyrt Antiseptic and disinfecting compositions having reduced iodine content

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2798023A (en) * 1957-07-02 zapapas etal
US2918400A (en) * 1956-04-16 1959-12-22 Chilean Nitrate Sales Corp Sanitizing compositions
NL124343C (es) * 1964-06-05
GB1412970A (en) * 1974-01-15 1975-11-05 Schering Ag Pharmaceutical preparations containing silicone rubber
DE2445971A1 (de) * 1974-09-24 1976-04-08 Schering Ag Arzneimittelwirkstofftraeger ii
US4053580A (en) * 1975-01-01 1977-10-11 G. D. Searle & Co. Microsealed pharmaceutical delivery device
US4107346A (en) * 1976-09-02 1978-08-15 Kravitz Hilard L Dietary salt compositions
US4275194A (en) * 1977-11-26 1981-06-23 Nihon Tennen Gas Kogyo Co., Ltd. Chitosan-iodine adduct
US4384960A (en) * 1979-11-13 1983-05-24 Polley R D Iodine dispenser and method of dispensing iodine
US4500337A (en) * 1980-09-03 1985-02-19 Young Robert W Adherent controlled release microbiocides containing hydrolyzable silanes and organic titanium compounds
US4420590A (en) * 1981-04-06 1983-12-13 Halex, Inc. Bacteriocidal resins and disinfection of water therewith
US4640956A (en) * 1985-06-13 1987-02-03 General Electric Company Iodine resistant silicone rubber compositions
FR2611735B1 (fr) * 1987-02-26 1989-06-16 Rhone Poulenc Chimie Composition elastomere silicone polyaddition contenant de l'iode pour le traitement de l'eau
FR2611733B1 (fr) * 1987-02-26 1989-06-16 Rhone Poulenc Chimie Composition a base de gomme diorganopolysiloxane contenant de l'iode pour le traitement des eaux

Also Published As

Publication number Publication date
CA1308837C (fr) 1992-10-13
FR2611734A1 (fr) 1988-09-09
BR8800803A (pt) 1988-10-04
DE3867510D1 (de) 1992-02-20
FR2611734B1 (fr) 1989-06-16
EP0283408A3 (en) 1988-09-28
GR3004218T3 (es) 1993-03-31
AU1211388A (en) 1988-09-01
JPS63243163A (ja) 1988-10-11
EP0283408A2 (fr) 1988-09-21
ZA881327B (en) 1988-08-26
JPH0580953B2 (es) 1993-11-10
ATE71396T1 (de) 1992-01-15
EP0283408B1 (fr) 1992-01-08
US5114707A (en) 1992-05-19
AU596500B2 (en) 1990-05-03

Similar Documents

Publication Publication Date Title
ES2028342T3 (es) Composicion elastomera de silicona que contiene yodo y que reticula por reaccion de policondensacion.
NO871644D0 (no) Slagseig polyamid-formmasse.
DK1098631T3 (da) Farmaceutisk præparat især beregnet til forebyggelse og behandling af radiomucositis og kemomucositis
ES2052654T3 (es) Preparacion polimera endurecible por agua.
ES2027784T3 (es) Composicion a base de elastomero de silicona, vulcanizable en caliente, que contiene yodo.
SE7900136L (sv) Flytbarhetshjelpmedel
FR2534778B1 (fr) Installation de traitement thermique de morceaux de matieres animales
ES2075890T3 (es) Compuestos de estaño (iv) eventualmente quelatados utilizables principalmente como catalizadores latentes.
BR0215643A (pt) Adjuvante imunológico de tecido solidificado
ES516422A0 (es) "procedimiento e instalacion para la obtencion de metano y para el tratamiento de liquidos acuosos que contengan sustancias organicas".
ATE71645T1 (de) Durch polyaddition haertbare, jod enthaltende siloxan-elastomer-zusammensetzung.
FR2154476A1 (es)
MX6979E (es) Composicion polimerica mejorada para la fabricacion de forros impermeables para depositos de agua o liquidos de desecho
ES548587A0 (es) Procedimiento para el tratamiento de liquidos sobre materiasgranulares
MX160893A (es) Procedimiento para la preparacion de polibis-triazinilimidas,utiles como estabalizadores de polimeros
KR870005943A (ko) 동물분뇨를 이용한 유기질 비료의 제조 방법
ES549671A0 (es) Procedimiento de obtencion de composiciones para el trata- miento de infecciones por rinovirus
DE3778938D1 (de) Harzzusammensetzungen fuer beschichtungszwecke, ihre herstellung und diese enthaltende beschichtungsmassen.
ES516196A0 (es) "procedimiento con su dispositivo correspondiente para el tratamiento de residuos industriales".
KR890001568A (ko) 돼지 이질의 예방 및 치료제
ES2038405T3 (es) Dispositivo de filtro.
PT71725B (pt) 2-(2-chlor-4-cyclopropyl-phenyl-imino)-imidazolidin dessen saureadditionssalze diese enthaltende arzneimittel und verfah- ren zur herstellung derselben
UA13695A1 (uk) Спосіб підвищеhhя стійкості ссавців до загальhого охолоджеhhя
KR890003626A (ko) 인산부산석고의 중화방법
MX17601A (es) Composicion para el tratamiento de leishmaniasis yprocedimiento para su preparacion .

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 283408

Country of ref document: ES